leadnearLeadnear
HomePricingFAQCompare
Ultragenyx logo
Verified

Ultragenyx

Pharmaceuticals

Founded: 2010
Headquarters: 60 Leveroni Ct, Novato, California, 94949, United States
Overview
Location
California, United States
Headquarter
60 Leveroni Ct, Novato, California, 94949, United States
Contact Number
(415) 483-8800
No of Employees
1,164 Employees
Industry
Pharmaceuticals
Contact Email
Not Available
Company Type
Public Company
Founded
2010
CEO
Not Available
Codes
SIC Code 87,873 | NAICS Code 54,541
Annual Revenue
$560.2 Million
Total Funding
$1.2B
Recent Funding Amount
$330M
No of Funding Rounds
8
Social Handles

Company Overview

Ultragenyx is a biopharmaceutical company founded in 2010 that focuses on developing treatments for rare and ultra-rare genetic diseases. The company specializes in creating biologics and small-molecule therapeutics targeting specific genetic disorders with limited treatment options. Ultragenyx's product pipeline includes treatments for metabolic disorders, bone diseases, and enzyme deficiencies. The company operates globally with a strong presence in North America, Europe, and Asia, collaborating with research institutions and pharmaceutical partners to advance its clinical programs. Ultragenyx maintains a commitment to addressing the unmet medical needs of patients with rare genetic conditions through innovative therapeutic approaches.

Employees by Level

C-Level

9

VP-Level

103

Director

640

Manager

330

Non-Manager

786

Top Contacts

1464

Top C-suite Members of Company

Connect with key decision-makers at Ultragenyx. View contact details of C-suite executives and leadership team.

NameTitleContact
Howard HornChief Financial Officer & Executive VP, Corpoh****[email protected]
Ernie MeyerExecutive VP & Chief Human Resources Officere****[email protected]
Alyssa MooreChief of Staff, Senior VP, Head of Program &a****[email protected]
Theodore HuizengaChief Accounting Officer (CAO) & Senior VPt****[email protected]
Edes BalhesDirector, Financial Planning Analysis & Contre****[email protected]
Nishant PansariVice President, Corporate Controllern****[email protected]
Drew OBrienControl Vice President, Qualityd****[email protected]
Theodore HuizengaChief Accounting Officer (CAO) & Senior VPt****[email protected]
Howard HornChief Financial Officer & Executive VP, Corpoh****[email protected]
Dennis HuangTechnical Chief & Operations Officer & Executd****[email protected]
Matthew FullerHead Vice President, Gene Therapy Researchm****[email protected]
Philip HornickHead Senior VP, Global Medicalp****[email protected]

Employees Contact

Are you Seeking to connect with decision-makers? Acquire their contact info, including emails and phone numbers, from credible sources like LinkedIn or trusted websites.

NamePositionPhoneEmailProfile
Deborah Marsden
Medical Affairs
******8800[email protected]
Bria Martin
Organizational Strategy Development
******8800[email protected]
Nick Mordwinkin
Corporate Strategy
******4135[email protected]
Natalie Mcwilliams
Executive Assistant
******4563[email protected]
Sarah Chesler
Mngr
******8843[email protected]
Alison Skrinar
Clinical Sciences
******8800[email protected]
Lee Sayers
Program Management
******4933[email protected]
Arjun Natesan
Executive
******8800[email protected]
Eric Peng
Bioanaytical
******8800[email protected]
Maha Hermes
Marketing
******4488[email protected]
Kathy Maloney
Hr
******8800[email protected]
Beatrice Cookson
Marketing
******8800[email protected]
Amanda Schmieder
Project Pmo
******8800[email protected]
Perry Wood
Research
******8800[email protected]
Beatrice Cookson
Marketing
******5000[email protected]
Karishma Amin
Medical Writer
******4343[email protected]
Kathy Lampl
Medical Clinical Development
******5490[email protected]
Dorian Yablin
Hr Recruiter Office
*******8800[email protected]
Anna Frid
Clinical Trial
******8800[email protected]
Pedro Rivera
Qa Validation
*******4227[email protected]
Ashley Dress
Clinical Trial
*******7201[email protected]
Javier Martin
Clinical Development
******2687[email protected]
Smithu Desai
Clinical Trial
******5052[email protected]
Luis Hardman
Patient Services
******8800[email protected]
John Truong
It Patient Services
******3409[email protected]
Betsy Kitchens
Publication Planning
******8800[email protected]
Tom Kassberg
Chief Business Officer
******8800[email protected]
Joseph Chen
Cmc Quality Control
******8130[email protected]
Jeff Lewis
Senior Director, Qa Computer Systems And Data
******8800[email protected]
Kiran Akula
Scientist
******1210[email protected]
Alexander Butte
Clinical Trial
******8800[email protected]
David Libby
Government Affairs Market Access
*******6873[email protected]
Brandi Blount
Senior Manager, Clinical Data Management
******5929[email protected]
Jennifer Yoo
Drug Safety Pharmacovigilance
******5576[email protected]
Christopher Scott
Accounting Operations
******2723[email protected]
Yael Weiss
Search Evaluation Business Development
******8800[email protected]
Amy Smietana
Director
******3887[email protected]
Bob Hostutler
Clinical Program
******9133[email protected]
Jake Furber
It G&a
******8400[email protected]
Marcus Andrews
Toxicology
*******3147[email protected]
Jin Zhou
Cell Culture Process Development
******1681[email protected]
Kendra Benson
Program Development
******8800[email protected]
Bijoy Banerjee
It Applications
******8800[email protected]
Claire Wang
Tax
******6912[email protected]
Xiaoxiao Lu
Statistical Programmer
*******0315[email protected]
Alexandra Trotier-faurion
Senior Scientist Ascdir
******8800[email protected]
Rui Gregorio
Information Technology
******2201[email protected]
Thomas Cho
Procurement
******8800[email protected]
Caryn Mazzie
Brand Strategy
******7166[email protected]
Paul Scott
Research
******2709[email protected]
William Coble
Gxp Training
******4736[email protected]
Marcy Florian
Clinical Qa
******8800[email protected]
Dapeng Zhang
Statistical Progarmming
******9544[email protected]
Cynthia Rich
Regulatory Operations
******8800[email protected]
Curtis Woodard
Patient Diagnostic Services
*******5157[email protected]
Chevette Radford
Ultracare Liaison Rare Disease Account Manager
*******3363[email protected]
Alyssa Moore
Program Management Office Program Portfolio Management
******1466[email protected]
Kay Newell
Document Management
******8800[email protected]
Julie Taylor
Bioanalytical Methods Development
******8800[email protected]
Suresh Pullela
Quality Biologics
******8800[email protected]
Forbes Mcnaught
System Engineer
******8800[email protected]
Alberto Gonzalez
Commercial Planning
******7487[email protected]
Jon Davies
Employee Development Engagement
******8800[email protected]
Kelli Petersen
Program
******8800[email protected]
Tony Nguyen
Clinical Systems Records Management
******8800[email protected]
Yvonne Gwinnell
Talent Acquisition
******8800[email protected]
Benjamin Ehrhart
Corporate Counsel Compliance Latam Operations
******8412[email protected]
Jack Stiefel
Marketing Routes To Care
******0285[email protected]
Theresa Lowry
Total Rewards
*******9981[email protected]
Todd Day
It R And D Systems Manager
*******0801[email protected]
Elaine Eborall
Senior Vice President Quality And Compliance
******8800[email protected]
Steve Catalano
Commercial Field West
******0501[email protected]
Melita Dvorak-ewell
Program Portfolio Management
******8800[email protected]
Chelsea Garcia
Benefits
******8800[email protected]
Emily Radomile
Clinical Program
******8800[email protected]
Christianne Parotti
Drug Safety Pharmacovigilance
******0953[email protected]
Mark Milberg
Clinical Procurement Outsourcing
******8074[email protected]
Mindy Walker
Administrative To
******8800[email protected]

Email Formats

Discover the email patterns used at Ultragenyx to connect with the right people.

Email Verification Tool

Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.

Enter a person's name or an email address to verify

Technology Stack

Technology

Gupy
Gupy

Gupy technology used by Ultragenyx

Zingfit
Zingfit

Zingfit technology used by Ultragenyx

DocuSign
DocuSign

DocuSign technology used by Ultragenyx

WordPress.org
WordPress.org

WordPress.org technology used by Ultragenyx

Frequently Asked Questions

What is the address of Ultragenyx's headquarters?

Ultragenyx is headquartered at 60 Leveroni Ct, Novato, California, 94949, United States.

How can I contact Ultragenyx by phone?

You can reach Ultragenyx by calling their customer support number at (415) 483-8800.

Which stock symbol does Ultragenyx trade under?

The stock ticker for Ultragenyx is RARE.

What is the official website for Ultragenyx?

You can visit Ultragenyx's official website at www.ultragenyx.com.

How much revenue does Ultragenyx generate?

Ultragenyx reports an annual revenue of approximately $560.2 Million.

What is the SIC code for Ultragenyx?

The Standard Industrial Classification (SIC) code for Ultragenyx is 87,873.

What is the NAICS code for Ultragenyx?

Ultragenyx falls under the NAICS code 54,541.

How many people work at Ultragenyx?

Ultragenyx has a workforce of about 1,164 employees.

Which industry is Ultragenyx part of?

Ultragenyx operates in the Pharmaceuticals, Healthcare industry.

Which technologies are used by Ultragenyx?

Ultragenyx utilizes technologies like Gupy, Zingfit, DocuSign, WordPress.org.

Who is the Chief Executive Officer (CEO) of Ultragenyx?

The CEO of Ultragenyx is .

How can I get in touch with Ultragenyx?

To contact Ultragenyx, call (415) 483-8800 or visit their website at www.ultragenyx.com

Is Ultragenyx a publicly traded company?

Yes, Ultragenyx is publicly listed and trades under the stock symbol RARE.

How much total funding has Ultragenyx secured so far?

To date, Ultragenyx has raised $1.2B across 8 funding round(s).

Who are the main competitors of Ultragenyx?

Key competitors of Ultragenyx include Agios, BioMarin, Kite Pharma, Amicus Therapeutics

Which companies has Ultragenyx acquired?

Acquisitions by Ultragenyx include dimentiontx.com .

Who holds the CFO position at Ultragenyx?

Howard Horn serves as the Chief Financial Officer (CFO) at Ultragenyx.

Where can I find Ultragenyx on social media?

You can follow Ultragenyx on Linkedin, Twitter, Facebook to stay updated with their latest news and services.

When did Ultragenyx complete its most recent funding round?

Ultragenyx latest funding round closed on Feb 26, 2019 with the amount of $330 Million

Who are the investors in Ultragenyx?

Ultragenyx is backed by 20 investors : F-Prime Capital, TPG Biotech, Pappas Ventures and HealthCap Partners.

Generate quality leads for your business

Connect with anyone who has a LinkedIn URL, regardless of their

industry, department, company, or country.

Free Credits to claim
No credit card needed
Instant leads result